Remedium Lifecare secures Rs. 182.7 crore export deal
The CDMO upgrade represents a transformational step for Remedium Lifecare
The CDMO upgrade represents a transformational step for Remedium Lifecare
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
A new weapon in the global fight against malaria
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health
Experts urge early detection & better access to care
Subscribe To Our Newsletter & Stay Updated